Had the deal not been struck, analysts said, Ranbaxy could have launched its generic Lipitor (atorvastatin) in the US by March 2010. Now, it will be able to do so only in November 2011
Top Section
Explore Business Standard
Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Had the deal not been struck, analysts said, Ranbaxy could have launched its generic Lipitor (atorvastatin) in the US by March 2010. Now, it will be able to do so only in November 2011
First Published: Jun 20 2008 | 12:00 AM IST